SCHEMBL6868209

SCHEMBL6868209

COC(=O)Nc1nc2c(OC)ccc(N)c2s1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.59
HPGD P15428 4/20 0.59
KDM4E B2RXH2 3/20 0.59
MAPT P10636 4/20 0.58
TSHR P16473 2/20 0.58
HSD17B10 Q99714 2/20 0.58
SMN1; SMN2 Q16637 2/20 0.54
LMNA P02545 2/20 0.54
KMT2A Q03164 3/20 0.53
MEN1 O00255 2/20 0.53
POLB P06746 1/20 0.53
CHRM4 P08173 5/20 0.51
DUSP3 P51452 1/20 0.51
PKM P14618 1/20 0.49
ATM Q13315 1/20 0.49
NPSR1 Q6W5P4 1/20 0.48
DYRK1A Q13627 1/20 0.48
ADORA2A P29274 1/20 0.47
ADORA2B P29275 1/20 0.47
ADORA1 P30542 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3053652 0.83 ALDH1A1 (0.59) ALDH1A1HPGDKDM4EMAPTTSHR
SCHEMBL3050636 0.82 ALDH1A1 (0.58) ALDH1A1HPGDKDM4EMAPTTSHR
SCHEMBL3038896 0.80 ALDH1A1 (0.50) ALDH1A1HPGDKDM4EMAPTTSHR
SCHEMBL3057561 0.80 ALDH1A1 (0.55) ALDH1A1HPGDKDM4EMAPTTSHR
SCHEMBL3057462 0.80 ALDH1A1 (0.62) ALDH1A1HPGDKDM4EMAPTTSHR
SCHEMBL6875154 0.79 ALDH1A1 (0.54) ALDH1A1HPGDKDM4EMAPTTSHR
SCHEMBL3047582 0.79 ALDH1A1 (0.54) ALDH1A1HPGDKDM4EMAPTTSHR
SCHEMBL3047579 0.79 ALDH1A1 (0.54) ALDH1A1HPGDKDM4EMAPTTSHR
SCHEMBL3055761 0.79 ALDH1A1 (0.48) ALDH1A1HPGDKDM4EMAPTTSHR
SCHEMBL3053134 0.78 ALDH1A1 (0.53) ALDH1A1HPGDKDM4EMAPTTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1456188-A1 7-AMINO-BENZOTHIAZOLE DERIVATIVES AS ADENOSINE RECEPTOR LIGANDS F. HOFFMANN-LA ROCHE AG (CH) 2004-09-15 EP disclosed
US-6713499-B2 ADENOSINE RECEPTOR AGONIST HOFFMAN-LA ROCHE INC. 2004-03-30 US disclosed
US-20030153566-A1 7-Amino-benzothiazole derivatives F. HOFFMANN-LA ROCHE AG (CH) 2003-08-14 US disclosed
WO-2003053946-A1 7-AMINO-BENZOTHIAZOLE DERIVATIVES AS ADENOSINE RECEPTOR LIGANDS F. HOFFMANN-LA ROCHE AG (CH) 2003-07-03 WO disclosed
WO-2003053946-A1 7-AMINO-BENZOTHIAZOLE DERIVATIVES AS ADENOSINE RECEPTOR LIGANDS F. HOFFMANN-LA ROCHE AG (CH) 2003-07-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030153566-A1 7-Amino-benzothiazole derivatives ADORA1, ADORA2A, ADORA3 ALDH1A1 308/4885HPGD 3332/4885KDM4E 3134/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.